1950s

Maxine F. Singer, Ph.D. ’57, retired from a 14-year tenure as president of the Carnegie Institution of Washington and in January 2003 was named chair of the board of directors of the Whitehead Institute for Biomedical Research in Cambridge, Mass. Singer, who previously served as a member of the board, has earned a strong reputation in science public policy for her studies of risks from recombinant DNA research and her support for the Human Genome Project.